Novo Nordisk's pricing strategies while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, that has accused the company of price gouging, pointing out the stark contrast concerning U.S. costs and those in Europe and copyright.The company states that proper usage of copyright, together with diet plan and exercise, "may well